AIP
SYNH

Ameritas Investment Partners’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Ameritas Investment Partners’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-25,886
Closed -$1.09M – 3128
2023
Q2 		$1.09M Sell
25,886
-514
-2% -$20.8K 0.04% 557
2023
Q1 		$940K Hold
26,400
– – 0.04% 598
2022
Q4 		$946K Hold
26,400
– – 0.04% 608
2022
Q3 		$1.24M Sell
26,400
-955
-3% -$61.7K 0.06% 426
2022
Q2 		$1.96M Sell
27,355
-370
-1% -$27.1K 0.08% 249
2022
Q1 		$2.24M Hold
27,725
– – 0.08% 273
2021
Q4 		$2.85M Buy
27,725
+356
+1% +$34.2K 0.1% 219
2021
Q3 		$2.39M Hold
27,369
– – 0.09% 246
2021
Q2 		$2.45M Buy
27,369
+4,487
+20% +$379K 0.09% 255
2021
Q1 		$1.74M Buy
22,882
+1,900
+9% +$143K 0.07% 348
2020
Q4 		$1.43M Buy
20,982
+1,168
+6% +$72.8K 0.07% 387
2020
Q3 		$1.05M Buy
19,814
+1,733
+10% +$103K 0.05% 439
2020
Q2 		$1.05M Sell
18,081
-5,035
-22% -$271K 0.05% 436
2020
Q1 		$911K Buy
23,116
+133
+0.6% +$7.78K 0.05% 410
2019
Q4 		$1.37M Buy
22,983
+285
+1% +$15.3K 0.06% 391
2019
Q3 		$1.21M Sell
22,698
-414
-2% -$21.2K 0.06% 424
2019
Q2 		$1.18M Hold
23,112
– – 0.05% 442
2019
Q1 		$1.2M Hold
23,112
– – 0.06% 428
2018
Q4 		$909K Hold
23,112
– – 0.05% 487
2018
Q3 		$1.19M Buy
23,112
+2,100
+10% +$103K 0.06% 470
2018
Q2 		$985K Sell
21,012
-558
-3% -$23.1K 0.05% 539
2018
Q1 		$766K Hold
21,570
– – 0.04% 619
2017
Q4 		$940K Buy
21,570
+710
+3% +$33.2K 0.04% 565
2017
Q3 		$1.22M Hold
20,860
– – 0.06% 441
2017
Q2 		$1.22M Buy
20,860
+17,284
+483% +$898K 0.06% 436
2017
Q1 		$164K Buy
+3,576
New +$178K 0.01% 1165

Other funds holding SYNH

Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Natixis Advisors
Natixis Advisors Boston, Massachusetts $71.9B AUM 28.03% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Nomura Asset Management
Nomura Asset Management Tokyo, Japan $38.8B AUM 30.94% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return
CFB
Cullen/Frost Bankers San Antonio, Texas $10.1B AUM 29.18% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Ameritas Investment Partners's SYNH Position: Q3 2023 in Review

Ameritas Investment Partners sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q3 2023, closing a stake of 25,886 shares — an estimated $1.09M sold.

Ameritas Investment Partners first reported a position in SYNH in Q1 2017 and held it in 26 quarters. The position peaked at $2.85M in Q4 2021. 10 funds tracked by Wall St. Rank hold SYNH as of Q3 2023.

  • Ameritas Investment Partners reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q3 2023 after selling out during the quarter.
  • Ameritas Investment Partners sold 25,886 Syneos Health, Inc. Class A Common Stock shares in Q3 2023, an estimated $1.09M.
  • Ameritas Investment Partners first reported a position in Syneos Health, Inc. Class A Common Stock in Q1 2017 and held it in 26 quarters.
  • Ameritas Investment Partners's Syneos Health, Inc. Class A Common Stock position peaked at $2.85M in Q4 2021.
  • 10 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q3 2023.

Based on Ameritas Investment Partners's 13F filing for Q3 2023, filed 13 Nov 2023.